Mahmoud Abdelrahman Alkabbani
Mahmoud Abdelrahman Alkabbani publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Enzyme function and inhibition and Drug-Induced Hepatotoxicity and Protection.
- World rank
- #239,291 of 7,710,434 ranked researchers
- Rank in Egypt
- #609 of 36,277
- Works
- 36
- Citations
- 425
- Citations per work
- 11.8
What does Mahmoud Abdelrahman Alkabbani research?
Mahmoud Abdelrahman Alkabbani's work is mostly in Chemistry (30%), Biochemistry, Genetics and Molecular Biology (23%), Medicine (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1335.2%
- Physical Sciences1129.6%
- Chemistry1129.6%
- Everything else1027.8%
- Health Sciences37.4%
- Medicine37.4%
- 1Organic Chemistry30% of their works
- 2Molecular Biology23% of their works
- 3Pharmacology7% of their works
- 4Pharmacology6% of their works
- 5Cellular and Molecular Neuroscience3% of their works
- 6Plant Science3% of their works
Research topics
- Synthesis and biological activity
- Enzyme function and inhibition
- Drug-Induced Hepatotoxicity and Protection
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Inflammatory mediators and NSAID effects
- Phosphodiesterase function and regulation
- Neuroscience and Neuropharmacology Research
Which keywords describe Mahmoud Abdelrahman Alkabbani's research?
The keywords of their largest research topics: Anticancer Agents, Drug Discovery, Heterocyclic Compounds, Medicinal Chemistry, Carbonic Anhydrases, Inhibitors, Drug-Induced Liver Injury and Hepatotoxicity.
- cAMP Signaling
- Neurotransmission
- Triazines
- Inflammation
- Copper-Catalyzed Cycloaddition
- Hepatotoxicity
- Inhibitors
- Medicinal Chemistry
- Drug Discovery
- Anticancer Agents
- Heterocyclic Compounds
- Carbonic Anhydrases
- Drug-Induced Liver Injury
- Click Chemistry
- Cyclooxygenase-2 Inhibitors
- Synthesis
- Cyclic Nucleotide Phosphodiesterases
- Synaptic Plasticity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Anticancer Agents182 topics
- Drug Discovery163 topics
- Heterocyclic Compounds101 topic
- Medicinal Chemistry101 topic
- Carbonic Anhydrases81 topic
- Inhibitors81 topic
- Drug-Induced Liver Injury51 topic
- Hepatotoxicity51 topic
- Click Chemistry41 topic
- Copper-Catalyzed Cycloaddition41 topic
- Cyclooxygenase-2 Inhibitors41 topic
- Inflammation41 topic
- Synthesis41 topic
- Triazines41 topic
- Cyclic Nucleotide Phosphodiesterases31 topic
- Neurotransmission31 topic
- Synaptic Plasticity31 topic
- cAMP Signaling31 topic
Where does Mahmoud Abdelrahman Alkabbani work?
Mahmoud Abdelrahman Alkabbani's main affiliation in the publication record is Egyptian Russian University, Egypt.
How many publications and citations does Mahmoud Abdelrahman Alkabbani have?
OpenAlex counts 36 works and 425 citations for Mahmoud Abdelrahman Alkabbani, an h-index of 14, ranking #239,291 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mahmoud Abdelrahman Alkabbani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.